Notably, downstream of ACACA, the gene expression of Fatty Acid Synthase (FASN) corroborated this observation, demonstrating a significant reduction in lipogenesis in our steatosis model, and a significant elevation in lipogenesis under both nSMase and aSMase inhibition (Figure 4G). The gene discussed is SMPD2; the disease is steatosis.